OTCM
IDXAF
Market cap1.55bUSD
Aug 21, Last price
20.00USD
Name
Idex Biometrics ASA
Chart & performance
P/E
—
P/S
6,087.32
EPS
—
Vol. 1Y
—
Shs. 5Y
-21.99%
Rev. 5Y
-25.34%
Div Yld LY
—
Div Yld TTM
—
Revenues
254k
-69.80%
Net income
-10m
L-30.78%
CFO
-9m
L-50.95%
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Headquartered in Oslo, Norway, and established in 1996, IDEX Biometrics ASA is dedicated to developing and commercializing fingerprint authentication technology. The company's innovative biometric solutions are deployed globally, spanning markets in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. These cutting-edge systems are primarily utilized in contactless financial payment applications, secure access control, and various smart cards, including specialized card-based hardware for safeguarding digital currencies. IDEX Biometrics ASA predominantly caters to smart card manufacturers focused on financial payment systems and the burgeoning biometric payment card industry.
Key people
Stanley A. Swearingen
Chief Executive Officer · since 2018
Chief Financial Officer · since 2019
Anthony Eaton
Chief Technology Officer · since 2019
Paul Taylor
Vice President, Operations & Program Management · since 2018
Brian Roberts
Vice President, Product Management & Business Development · since 2017
David M. Orme
Senior Vice President, Sales & Marketing · since 2018
Sarah Mathews
Senior Director of Group Human Resources · since 2016
Chairman of the Board · since 1997
Director · since 2019
Lawrence John Ciaccia
Independent Director · since 2015
Independent Director · since 2015
Hanne Hovding
Independent Director · since 2007
Headquarters & legal address
Henrik Ibsens gate 90
Oslo, 03 0255
NO
Oslo, 03 0255
NO
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||